4SC Discovery is a drug discovery company based in Planegg-Martinsried near Munich. It was founded in December 2011 as a wholly owned subsidiary of 4SC AG.
4SC Discovery offers services for small molecule research from hit finding right through to preclinical development. Our proprietary research programmes focus on indications with a high unmet medical need, in particular autoimmune diseases and cancer. We offer extensive partnering opportunities for our proprietary projects, with the goal to jointly advance these through to preclinical development.
Thanks to our innovative project pipeline and our customer orientated research service portfolio, 4SC Discovery is an attractive partner for pharmaceutical and biotechnology companies seeking expert research partners.
10 - 14 August 2014, 248th ACS National Meeting, San Francisco,
Poster presentation MEDI 56:
“Kv1.3 inhibitors: En route to clinical trials”